FDA medical devices
Classify a medical device, select the right submission pathway and assemble the evidence package.
In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746
Classify an IVD, plan performance evidence, and verify any remaining legacy transition conditions.
Manufacturers and other economic operators placing covered in vitro diagnostic devices on the EU market under IVDR.
The required technical and conformity evidence, declaration, registration and any needed notified-body certificate.
A legacy deadline depends on earlier conditions, such as a valid route, no significant change and timely notified-body steps. Check EUDAMED obligations by module and role.
Monitor outstanding evidence, external dependencies and authority responses due. Bring changes to the assessed product or service to the decision owner.
Fill this in with your sponsor and send it to the people who own the work.
EU in vitro diagnostics kickoff brief Business reason and required outcome [Contract, obligation or approval] Scope and exclusions [Entities, systems or activities, and reasons] Fixed deadlines and internal milestones [Date, source and owner] Executive sponsor and authorized signer [Names] Project lead and backup [Names] First workstream Classify the IVD and confirm the route · Regulatory affairs [Name and due date] People, effort and external costs [Estimate, owner and contingency] Evidence folder and reviewer access [Location, access owner and review date] Decisions and blockers [Item, options, owner and decision date] First week 1. Ask the first-step owner to bring the most recent system, activity or product inventory and the contract or rule driving the work. 2. Write down the proposed route, what eligibility depends on and who can verify it. Pull a representative test, evidence record or service use case to check the boundary. 3. Record what the sponsor approved, open questions, work owners and the next date a decision is needed. Send the brief to everyone who needs to contribute evidence.
A developer adds a new screening claim to a legacy assay. Regulatory affairs checks whether this is a significant change before relying on the old certificate. The performance team maps the claimed population to evidence and organises any new studies.
Use the separate device regulation for a product outside the IVD definition.
Structure the quality system supporting design, performance evidence and post-market work.
Eligible devices under Article 110(3b)(c) must meet the notified-body application condition in Article 110(3c). The written agreement condition has its own deadline.
Official reference (opens in a new tab)This date applies only under the relevant transitional provisions and conditions. Eligible Class C, Class B and sterile Class A categories can have later dates.
Official reference (opens in a new tab)Checklist, instructions and 12 templates.
| Step | Owner | When to act | Estimated target | Deliverables | Status |
|---|---|---|---|---|---|
| Classify the IVD and confirm the route | Regulatory affairs | At design initiation and when claims change | Set a start date | Classification rationale; Route memo; Applicability matrix | Open |
| Plan and generate performance evidence | Clinical + analytical performance teams | Before conformity assessment | Set a start date | Testing matrix; Study protocols; Performance evaluation file | Open |
| Build the technical file and complete assessment | Quality + regulatory affairs | Before placing covered devices on the market | Set a start date | Safety requirements matrix; Technical documentation; Declaration | Open |
| Maintain registration and post-market evidence | Regulatory operations + surveillance lead | Before initial market entry and ongoing | Set a start date | Registration/listing record; Surveillance file; Periodic reports | Open |
Targets use illustrative calendar-day estimates and assume the steps run in sequence. Check official dates and agree real durations with your team.
Record the intended purpose and apply classification rules. Confirm notified-body involvement, operator duties and whether any legacy route remains available.
Fictional details. Use the same fields with evidence from your work.
A reviewer can reach the same decision using the source and facts, or see exactly what remains unresolved.
Send confirmed obligations to the delivery team and record any unresolved decision with the appropriate authority or specialist.
Fictional details. Use the same fields with evidence from your work.
A reviewer can reach the same decision using the source and facts, or see exactly what remains unresolved.
Send confirmed obligations to the delivery team and record any unresolved decision with the appropriate authority or specialist.
Fictional details. Use the same fields with evidence from your work.
A reviewer can reach the same decision using the source and facts, or see exactly what remains unresolved.
Send confirmed obligations to the delivery team and record any unresolved decision with the appropriate authority or specialist.
Map scientific validity, analytical performance and clinical performance to specific claims. Record study, sample and acceptance criteria and maintain a performance evaluation record.
Fictional details. Use the same fields with evidence from your work.
Every essential claim and risk control has evidence or a documented justification for the gap.
Give the approved protocol to the testing team and the traceability matrix to the submission owner.
Fictional details. Use the same fields with evidence from your work.
Every essential claim and risk control has evidence or a documented justification for the gap.
Give the approved protocol to the testing team and the traceability matrix to the submission owner.
Fictional details. Use the same fields with evidence from your work.
A reviewer can follow a claim from label to evidence and see what was excluded or remains uncertain.
Give the approved performance evaluation to regulatory affairs, quality and the notified body where required.
Reconcile QMS evidence, safety requirements, labels, traceability and performance findings. Coordinate notified-body assessment where required and retain the declaration.
Fictional details. Use the same fields with evidence from your work.
A different person can operate the control or test it using the matrix and its evidence links.
Give the baseline to control owners and the assessor before walkthroughs or sampling.
Fictional details. Use the same fields with evidence from your work.
The submitted package can be recreated from the index and the receipt is linked to the exact files.
Send the approved package through the official channel. Treat the download as an index, and use issuer forms where required.
Fictional details. Use the same fields with evidence from your work.
The signer can explain the basis for each statement and the record reflects the required scope and period.
Give the executed document to the relevant recipient under the engagement or regulation. Use the worksheet to organize review.
Check applicable EUDAMED modules, vigilance, surveillance and performance follow-up. Reassess changes and maintain the required reporting records.
Fictional details. Use the same fields with evidence from your work.
The original can be traced to the issuer and its scope and date match the engagement or application.
Send the verified record or approved summary to decision makers. The download is a tracking sheet for the original document.
Fictional details. Use the same fields with evidence from your work.
The submitted package can be recreated from the index and the receipt is linked to the exact files.
Send the approved package through the official channel. Treat the download as an index, and use issuer forms where required.
Fictional details. Use the same fields with evidence from your work.
The period, evidence and required metrics are complete and the reviewer can follow up on open items.
Send the approved report to the required recipient and give ongoing actions to service owners.